131 related articles for article (PubMed ID: 7749683)
1. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer.
Neoptolemos JP; Oates GD; Newbold KM; Robson AM; McConkey C; Powell J
Br J Surg; 1995 Feb; 82(2):184-7. PubMed ID: 7749683
[TBL] [Abstract][Full Text] [Related]
2. Jass' classification revisited.
Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic value of Jass' histopathological classification of cancer of the left colon and rectum].
Secco GB; Fardelli R; Lapertosa G; Fulcheri E; Rovida S; Ratto GB; Prior C
Minerva Chir; 1990 Nov; 45(21-22):1347-53. PubMed ID: 2097559
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the Jass histopathologic classification in left colon and rectal cancer: a multivariate analysis.
Secco GB; Fardelli R; Campora E; Lapertosa G; Fulcheri E; Rovida S; Motta G
Digestion; 1990; 47(2):71-80. PubMed ID: 2292355
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of Jass classification of rectal cancer compared to original Dukes system].
Szynglarewicz B; Grzebieniak Z; Forgacz J; Pudełko M; Rapała M
Wiad Lek; 2005; 58(9-10):491-4. PubMed ID: 16529057
[TBL] [Abstract][Full Text] [Related]
6. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the prognostic accuracy of Astler-Coller's and Jass' classifications of colorectal cancer.
Li Destri G; Rinzivillo C; Vasquez E; Di Cataldo A; Puleo S; Licata A
Tumori; 2001; 87(3):127-9. PubMed ID: 11504364
[TBL] [Abstract][Full Text] [Related]
8. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
9. Jass staging is a predictor of outcome following "curative" resection of Dukes' B colorectal carcinoma.
Mander BJ; Carney LJ; Scott HJ; Donaldson DR
Surgeon; 2006 Aug; 4(4):227-30. PubMed ID: 16892840
[TBL] [Abstract][Full Text] [Related]
10. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
11. Association of ploidy and cell proliferation, Dukes' classification, and histopathological differentiation in adenocarcinomas of colon and rectum.
Wahlström B; Branehög I; Stierner U; Sunzel H; Holmberg E
Eur J Surg; 1992 Apr; 158(4):237-42; discussion 242-3. PubMed ID: 1352139
[TBL] [Abstract][Full Text] [Related]
12. Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.
Ilyas M; Novelli M; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Talbot IC
J Clin Pathol; 1997 Mar; 50(3):218-22. PubMed ID: 9155672
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer.
Kovac D; Rubinic M; Krasevic M; Krizanac S; Petrovecki M; Stimac D; Melato M
Anticancer Res; 1995; 15(5B):2301-2. PubMed ID: 8572642
[TBL] [Abstract][Full Text] [Related]
14. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Robinsky B; Sass R; Fisher B
Dis Colon Rectum; 1989 Nov; 32(11):944-9. PubMed ID: 2478350
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.
Evertsson S; Bartik Z; Zhang H; Jansson A; Sun XF
Int J Oncol; 1999 Jul; 15(1):53-8. PubMed ID: 10375593
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
17. Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system.
Davis NC; Evans EB; Cohen JR; Theile DE
Dis Colon Rectum; 1984 Nov; 27(11):707-13. PubMed ID: 6499604
[TBL] [Abstract][Full Text] [Related]
18. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
19. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
20. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
